References

Ed Broussard

CEO & Co-Founder

“Bamburgh’s support went well beyond just the professional advice, industry contacts and investment process management which delivered strong offers for both private equity and trade in parallel. They were ingrained in our leadership team, driving our strategic thinking and supporting the founders through the emotional process of finding the right long-term partner for the business we had created. They helped us optimise the business and the transaction for long term value and ultimately brokered a deal to sell to Accenture that delivered for our team, the founders and for Accenture.”

Nigel Rawlings

CEO & Co-Founder

“At Rise Homes we sought the support of Bamburgh Capital to raise funding for our next batch of Build To Rent schemes having successfully developed several such schemes for different partners previously.

I am pleased to say that Bamburgh Capital successfully introduced us to The British Strategic Investment Fund managed by Gresham House PLC who have funded both ‘The Depot’ and ‘The Mailbox’ for us and are looking to do much more with us in future. Bamburgh Capital were instrumental in securing and finalising these arrangements.”

Simon Bryson

CEO & Co-Founder

“We’ve worked with Alex and the Bamburgh Capital team since our first fundraising in 2012. They supported us in establishing an investable business proposition and sourcing investors and have continued to support the Proveca team throughout our evolution. We appreciate and value our relationship, and the sensible corporate finance advice and business analysis support they provide.”

Jon Summers

CBO & Co-Founder

“Bamburgh Capital have been a core part of the Mudano advisory team for many years, supporting the executive in setting business strategy driven by value creation and realisation.  Their expertise and insight has helped shape the business at every step of the way, ultimately, delivering significant outcomes for the team and their clients.”

Tom Rowley

Director

“Bamburgh Capital were appointed by NorthEdge Capital and the board of directors to coordinate and manage the IPO of Ramsdens Financial. The outcome was a successful IPO for Ramsdens and its leadership team which achieved our objective as investors. Bamburgh Capital’s knowledge, expertise and contacts were invaluable throughout the process.”

Dr Stewart White

CEO & Co-Founder

“The team helped me to establish Collbio Limited which then became Collagen Solution plc. The team were able to access capital and provide both strategic and detailed transactional expertise as we created the business together through a series of three acquisitions, including the reverse takeover of a listed company. The support was commercially forensic and hands-on. I have no hesitation in recommending Alex and the team.”

Sue Beecroft

CEO

“Alex and the Bamburgh Capital team were awesome. They helped us to prepare and negotiate a sale of Harvey Walsh to Open Health which has been a fantastic outcome for everyone involved. Alex helped us to understand and supported us as we agreed complex aspects to the transaction. Our relationship with Bamburgh Capital is long term and we have no doubt that we will work together in the future.”

Dr Cath Booth

CEO & Co-Founder

“Bamburgh Capital helped me to raise capital for both the purchase of Epistem and the development of future services. The Epistem purchase was an MBO and Bamburgh Capital led the difficult negotiations with Genedrive plc and helped me to prepare for investment discussions, providing both strategic advice and hands on help. Bamburgh Capital investigated sources of capital and then introduced me to four carefully selected investors, all of whom made offers to invest. They led these negotiations on my behalf and secured an excellent funding package. Alex Clarkson was the lead and was always available and ready to help and provide advice and sound judgement, as were other members of the Bamburgh Capital team including David Evans and Chris Brinsmead.”

Dr Ray Fisher

CEO & Co-Founder

“The team helped me, and my board explore a number of strategic options for Peakdale Molecular which resulted in a favourable sale to Concept Life Sciences. They provided excellent, commercial advice and were tenacious in the execution of the transaction. Subsequently I have worked successfully with Diagnostic Capital again in establishing a new venture called Neudrive”

Adam Sullivan

CEO & Co-Founder

“Bamburgh Capital provided excellent advice to the management team during our sale to the Bastide Group. There were multiple bidders and the interests of our private equity owners had to be managed alongside the bidders wishes to develop relationships and alignment with management. Bamburgh Capital helped us to navigate successfully through these negotiations, providing good quality commercial advice throughout”

Jamie Hopwood

CEO & Co-Founder

“The Bamburgh Capital team provided excellent corporate finance advice and hands-on support during our sale to Cabot Financial. They established and managed a process with multiple bidders and helped us agree a complex deal structure which brought together a number of shareholders. We were growing rapidly, and they helped us through a difficult due diligence exercise”

John McArthur

CEO & Co-Founder

“Alex Clarkson was a key member of the Zeus Capital team who identified Tracsis as a business & management team with the potential for value accretion on the public markets, raising the initial capital and overseeing the initial acquisitions making use of cash, paper and deferred consideration. Market Capitalisation at IPO was £7m in 2007 and has grown steadily to £145m since that time”

Manchester

10th Floor, Chancery Place,
50 Brown Street,
Manchester
M2 2JT

+44 (0)161 240 7550

Newcastle

Collingwood Buildings,
38 Collingwood Street,
Newcastle Upon Tyne
NE1 1JF

+44 (0)191 249 7441

© 2019 Bamburgh Capital Limited. All Rights Reserved. Registered in England and Wales No. 07155076. Registered Office: 10th Floor, Chancery Place, 50 Brown Street, Manchester M2 2 JT. Bamburgh Capital Limited is regulated and authorised by the Financial Conduct Authority.